| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f6618ffa97d621cdfe9437fd02fcb7a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-374 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-38 |
| filingDate |
2020-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb3ae6239f86f1705b128fde9baa185d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ae88ffb2f3b829e15b898e3377f89b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36a691e1dbe5160bc959f4ce0139c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392035fa188b36a19480e03603afebcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba19962594d2ccb3fd961eb6c98bca5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25447541c3889bf70659584f2a2b18c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c0997a1a387567a1511d3acf29ef97 |
| publicationDate |
2022-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022369997-A1 |
| titleOfInvention |
Systems and methods for analyzing frequency-following response to evaluate central nervous system function |
| abstract |
Central nervous (“CNS”) health in subjects who have human immunodeficiency virus (“HIV”) or non-human-species analogs thereof is 102 evaluated or otherwise monitored by analyzing frequency following response (“FFR”). In general, one or more components of an FFR are analyzed, The FFR is measured in response to the administration of an acoustic stimulus to the subject. The acoustic stimulus includes a complex sound, which may include a consonant and a consonant-to-vowel transition. An indication of CNS health can be generated by measuring changes in the FFR components (e.g., over time or relative to normative data). |
| priorityDate |
2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |